Teknimed
Teknimed is a French medical device manufacturer that designs, develops, and produces biomaterials—PMMA bone cements, calcium phosphate bone substitutes, bioresorbable sports medicine implants, and spine cementoplasty systems—for surgeons and hospitals globally via an independent distributor network.
- Company typePrivate
- Founded1990
- HeadquartersVic-en-bigorre, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Teknimed does
Teknimed is a French medical device manufacturer founded in 1990 by Alain Léonard and headquartered in Vic-en-Bigorre, France, with manufacturing operations consolidated across three sites in Toulouse totaling 8,300 m². The company designs, develops, and produces biomaterials and ancillary mixing/delivery systems under four product ranges: orthopedic PMMA bone cements with and without antibiotics (GENTAFIX® with gentamicin, CEMFIX®); spine cementoplasty systems spanning multiple viscosities (F20®, SPINE-FIX®, OPACITY+®, HighV+®) and their dedicated mixing/injection devices (PureKIT® GUN, S5M, MedV+®, MINI-MALAX®, EASYKIT® M, B-Two® kyphoplasty balloon, vertebroplasty needles); bone substitutes based on hydroxyapatite and tricalcium phosphate (NANOGEL® hydroxyapatite nanoparticle gel, CERAFORM® biphasic HA/TCP, TRIHA+® β-TCP monophasic ceramic); and sports-medicine resorbable implants (EUROSCREW® NG and TCP NG interference screws, A'LINK'S® suture anchors, COLINK® fixation buttons, SUTUR'LINK® UHMWPE sutures, bioresorbable pins). Products are manufactured in-house in ISO 7 cleanrooms, exploiting vertical integration from compounding to finished device.
Underlying technology rests on proprietary formulations in biomaterials science: patented NANOGEL® hydroxyapatite nanoparticle technology (introduced in 2008 as the first calcium phosphate featuring hydroxyapatite nanoparticles), patented PureKIT® GUN mixing/injection system (2024), and bioresorbable PLA and PLA/TCP composite polymer implants. The historical R&D pipeline has produced surgeon-co-developed platforms sold to strategic acquirers, including the Equinoxe shoulder prosthesis (sold to Exactech) and the Spinejack spinal system (sold to Vexim, now part of Stryker), evidencing an external-to-the-company monetization pathway for innovation. Operations are governed by ISO 13485 certification, EU MDR (EU) 2017/745 (100% of range certified by 2024), FDA 21 CFR Part 820 compliance, and MDSAP participation; the company maintains over 1200 product registrations worldwide.
Teknimed commercializes through an indirect distribution model: independent medical device distributors with biomaterials experience purchase ex-works from the manufacturing facility and handle local registration, marketing, and sales to hospitals, surgical centers, and surgeons. A secondary OEM and private-label manufacturing revenue stream supplies other medical device companies. The company is founder/family-controlled as a Société par actions simplifiée (SAS), with Carole Léonard serving as CEO since 2011. No external institutional investment or funding rounds were identified in the source material, indicating organic, self-funded growth.
Teknimed firmographics
Firmographics- Name
- Teknimed
- Legal name
- TEKNIMED
- Website
- https://teknimed.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Teknimed is a French medical device manufacturer that designs, develops, and produces biomaterials—PMMA bone cements, calcium phosphate bone substitutes, bioresorbable sports medicine implants, and spine cementoplasty systems—for surgeons and hospitals globally via an independent distributor network.
- Ownership category
- akta.pro rank
Teknimed industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
- akta.pro secondary industries
- Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
Keywords
Where Teknimed is headquartered
LocationHeadquarters
- HQ city
- Vic-en-bigorre
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
Teknimed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Device Sales: Teknimed develops, manufactures and commercializes medical devices for orthopedic, spine, and sports medicine applications. Products include bone cements, bone substitutes, surgical instruments, and implants. Revenue is generated through direct sales to distributors who resell to healthcare facilities and surgeons.
- OEM and Private Label Manufacturing: Teknimed serves as a trusted partner for leading medical device companies, delivering reliable OEM (Original Equipment Manufacturer) and Private Label biomaterials. This includes custom manufacturing services for other medical device companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Teknimed product offering
Product offeringCore offering
Teknimed designs, develops, and manufactures medical devices and biomaterials for orthopedic, spine, sports medicine, and bone regeneration applications. Core offerings include PMMA bone cements (with and without antibiotics), calcium phosphate and hydroxyapatite-based synthetic bone substitutes, bioresorbable polymer implants (interference screws, suture anchors, fixation buttons, pins), and proprietary mixing/injection delivery systems used by surgeons in arthroplasty, vertebroplasty/kyphoplasty, and ligament/tendon reconstruction procedures. All products are manufactured in-house in France under ISO 13485, EU MDR, FDA 21 CFR Part 820, and MDSAP compliant quality systems and distributed globally through an independent medical device distributor network, supplemented by OEM and private label manufacturing services.
Product overview
Teknimed is a French medical device manufacturer specializing in biomaterials for orthopedic, spine, sports medicine, and bone substitute applications. The product portfolio consists of four main ranges: (1) Orthopedics - PMMA bone cements with/without antibiotics (GENTAFIX®, CEMFIX®), cement restrictors (CEMSTOP®), and mixing accessories; (2) Spine - a comprehensive cementoplasty system including bone cements at three viscosity levels (F20®, SPINE-FIX®, OPACITY+®, HighV+®), mixing and injection systems (S5M, MedV+®, MINI-MALAX®, EASYKIT® M, PureKIT®GUN LV/MV), kyphoplasty balloon (B-Two®), and vertebroplasty needles; (3) Sports Medicine - resorbable interference screws (EUROSCREW® NG & TCP NG), suture anchors (A'LINK'S®), fixation buttons (COLINK®), sutures (SUTUR'LINK®), and bioresorbable pins; (4) Bone Substitutes - hydroxyapatite gel (NANOGEL®) and biphasic/monophasic ceramics (CERAFORM®, TRIHA+®). Teknimed manufactures all products in-house in France under ISO 13485 quality management and EU MDR 2017/745 compliance.
Differentiator
Problem solved
Functional benefit
Brands
- GENTAFIX®: PMMA bone cements with Gentamicin for arthroplasty procedures, available in high, medium, and low viscosity formulations.
- TRIHA+®
- CERAFORM®
- NANOGEL®
- SPINE-FIX®
- F20®
- OPACITY+®
- HighV+®
- PureKIT®GUN
- EUROSCREW® NG & TCP NG
- A'LINK'S®
- CEMSTOP®
- COLINK®
- SUTUR'LINK®
- VERTEBROPLASTY NEEDLES
Products and services
- GENTAFIX® PMMA bone cements with Gentamicin (1 g base) for arthroplasty procedures, available in high viscosity (GENTAFIX® 1), medium viscosity (GENTAFIX® 3 MV), and low viscosity (GENTAFIX® 3) formulations for fixation of prosthetic components.
- CEMFIX® PMMA bone cements without antibiotics for arthroplasty procedures, available in high viscosity (CEMFIX® 1) and low viscosity (CEMFIX® 3) for fixation of prosthetic components.
- CEMSTOP® & Instrumentation Bio-absorbable cement restrictor for hip arthroplasty surgeries made of gelatin-based composition, available in 6 sizes, reabsorbed between 1 to 15 days after implantation, with elastic properties.
- F20® Spinal bone cement for palliative percutaneous cementoplasty procedures (vertebroplasty or kyphoplasty), indicated for fixation of pathological vertebral fractures from osteoporosis or benign/malignant lesions.
- SPINE-FIX® Low viscosity spinal radiopaque bone cement with 35% radiopaque agents (Barium Sulfate and Hydroxyapatite) for X-ray visualisation, intended for vertebroplasty, kyphoplasty and pedicular screw fixation augmentation procedures.
- OPACITY+® Spinal bone cement with 50% radiopaque agents (Zirconium dioxide and Hydroxyapatite) for enhanced X-ray visualization, indicated for palliative cementoplasty procedures.
- HighV+® Spinal Cement System Mixing and injection system dedicated to high viscosity bone cement with hydraulic pump and automatic overload safety mechanism, paired with HighV+® bone cement containing 36.4% radiopaque agents.
- PureKIT®GUN LV 3-in-1 mixing and injection system with SPINE-FIX® low viscosity bone cement for cementoplasty, providing up to 15 cc of fully transparent delivery.
- PureKIT®GUN MV 3-in-1 mixing and injection system with F20® medium viscosity bone cement for cementoplasty with low exothermicity below 45°C and up to 15 cc delivery.
- MedV+® Mixing and injection system for medium viscosity spinal bone cement during cementoplasty procedures with homogeneous and reproducible mix and controlled graduated delivery.
- S5M Mixing and injection system for medium and low viscosity spinal bone cements with automatic pressure-overload safety feature and up to 10 cc injection syringe.
- MINI‑MALAX® Mixing and injection system for low viscosity spinal bone cement with epicycloidal motion for homogeneous and reproducible mix and transparent mixing chamber.
- EASYKIT® M Mixing and injection system for low viscosity bone cements during cementoplasty procedures, with reproducible and homogeneous mixing and direct cement transfer into syringes up to 15 cc.
- B-Two® Kyphoplasty Balloon & Vertebral Access System (Inflatable Bone Expander System) with radiopaque balloon landmarks, sharpened access system, and 3 balloon catheter sizes (10, 15, 20 mm) for reduction of vertebral compression fractures.
- VERTEBROPLASTY NEEDLES Needles for percutaneous vertebroplasty with pusher, bevelled tip for cortical bone penetration, and lockable chuck handle with laser marking for depth control. Also available as biopsy range.
- EUROSCREW® NG & TCP NG Bioabsorbable interference screws made of 100% PLA (EUROSCREW® NG) or 70% PLA/30% TCP composite (EUROSCREW® TCP NG) for ACL/PCL and ankle lateral ligament reconstruction, featuring high torque resistance, self-tapping capability, and double thread design.
- A'LINK'S® Bioabsorbable suture anchor made of 70% Polylactic Acid (PLA) & 30% TriCalciumPhosphate (TCP) composite with UHMWPE sutures, designed for repair or reinsertion of shoulder tendons, featuring double thread design for high pull-out strength.
- COLINK® Standard & Adjustable Fixation button with loop for ligament/tendon reconstruction using UHMWPE sutures, available in Standard sizes (12-60 mm) and Adjustable one-size (15-60 mm) options with very high fixation strength.
- SUTUR'LINK® Ultra High Molecular Weight Polyethylene (UHMWPE) sutures with ergonomic needles for soft-tissue fixation, available in USP 2 and USP ⅗ sizes, intended for repair of ligaments, closure of soft tissues and tuberosity reinsertions.
- BIORESORBABLE PINS Polylactic acid (PLA) bioresorbable pins in 2 sizes (Ø 2.0 x L 60 mm and Ø 2.4 x L 60 mm) for stabilization of metatarsal and phalangeal realignment osteotomy procedures.
- NANOGEL® Synthetic injectable bone substitute made of hydroxyapatite nanoparticles in water (non-hardening gel), osteo-conductive hydroxyapatite gel for bone ingrowth in orthopedic or spine surgery.
- CERAFORM® Biocompatible synthetic biphasic ceramic made of 65% Hydroxyapatite (HA) & 35% Beta-Tricalcium Phosphate (β-TCP), osteo-conductive for bone ingrowth in orthopedic or spine surgery.
- TRIHA+® Synthetic monophasic ceramic made of 100% Beta-Tricalcium Phosphate (β-TCP), osteo-conductive and absorbable bone substitute for filling gaps or bone defects in orthopedic or spine surgery.
- Bowl & Spatula Disposable bone cement mixing set for arthroplasty, designed for mixing powder and liquid components of PMMA bone cements.
- OEM and Private Label Manufacturing Services Custom manufacturing services for other medical device companies across the biomaterials portfolio, delivering OEM (Original Equipment Manufacturer) and Private Label products utilizing Teknimed's in-house R&D, ISO 13485/ISO 7 cleanroom manufacturing, and regulatory expertise (EU MDR, FDA 21 CFR Part 820, MDSAP).
Quantifiable outcome
- 35 years of continuous operation and growth
- +2 more outcomes
Companies that use Teknimed
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Teknimed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Teknimed partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TRAUMASERVICEcoreTRAUMASERVICE is Teknimed's distribution partner for the Mexican market, collaborating on the VIII Guadalajara Spine Symposium. Teknimed attends this symposium alongside TRAUMASERVICE to share expertise through dedicated workshops and strengthen surgeon partnerships in the region.
Scale indicators9 records
Recent moves10 records
Expansion highlights5 records
Teknimed competitors and assessment
Company assessmentBroad incumbents
- Stryker: Global orthopedic and spine medical device leader with bone cement, bioresorbable implants, and vertebroplasty/kyphoplasty portfolios. Directly comparable as a broad incumbent overlapping Teknimed's spine cement and sports medicine categories, though Stryker operates at vastly greater scale.
- Zimmer Biomet: Major orthopedic device manufacturer with PMMA bone cements, joint reconstruction implants, and sports medicine products. Comparable across Teknimed's arthroplasty cement (GENTAFIX®, CEMFIX®) and extremity fixation categories.
- DePuy Synthes (Johnson & Johnson): Spine and orthopedic division of J&J MedTech with extensive trauma, spine, and biomaterials offerings. Comparable as a broad incumbent serving the same surgical specialties (arthroplasty, spine, sports medicine) that Teknimed targets.
- Medtronic (Spine division): Operates one of the largest spine surgery businesses globally, including vertebral augmentation (kyphoplasty) products. Comparable as a broad incumbent in Teknimed's spine cementoplasty segment.
Direct peers
- Heraeus Medical: Specialist manufacturer of PMMA bone cements (PALACOS®, COPAL®) and mixing/delivery systems for arthroplasty and spine. The closest direct peer to Teknimed given overlapping bone cement, antibiotic-loaded cement, and cement restrictor offerings with similar customer base.
- Bioventus: Orthobiologics-focused company with bone graft substitutes and joint preservation products. Comparable as a direct peer in synthetic bone substitutes (calcium phosphate ceramics) and osteobiologic materials targeting orthopedic and spine surgeons.
- BoneSupport: Specialist in injectable bone substitutes (CERAMENT®) for trauma and orthopedic indications. Direct peer in the synthetic bone substitute and bioresorbable biomaterial space with similar product positioning and surgeon customer base.
- Orthofix: Orthopedic and spine medical device company with bone growth stimulation, biologics, and fixation products. Comparable across Teknimed's sports medicine (interference screws, suture anchors) and bone substitute portfolio.
- Anika Therapeutics: Specialty medtech focused on joint preservation, cartilage repair, and regenerative biomaterials. Comparable as a direct peer in sports medicine soft-tissue repair and orthobiologic regeneration technologies overlapping Teknimed's resorbable polymer and bone substitute offerings.
- Biomatlante: European specialist in synthetic bone graft substitutes (calcium phosphate ceramics, HA/TCP composites) for orthopedic and dental surgery. Closely comparable to Teknimed's CERAFORM® and TRIHA+® bone substitute portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Teknimed social profiles
Digital presenceTeknimed compliance and trust
Trust signalCompliance5 records
Teknimed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Teknimed leadership team
Management profileNumber of profiles
Profiles2 records
Teknimed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Teknimed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Teknimed
What does Teknimed do?
Teknimed designs, develops, and manufactures medical devices and biomaterials for orthopedic, spine, sports medicine, and bone regeneration applications. Core offerings include PMMA bone cements (with and without antibiotics), calcium phosphate and hydroxyapatite-based synthetic bone substitutes, bioresorbable polymer implants (interference screws, suture anchors, fixation buttons, pins), and proprietary mixing/injection delivery systems used by surgeons in arthroplasty, vertebroplasty/kyphoplasty, and ligament/tendon reconstruction procedures. All products are manufactured in-house in France under ISO 13485, EU MDR, FDA 21 CFR Part 820, and MDSAP compliant quality systems and distributed globally through an independent medical device distributor network, supplemented by OEM and private label manufacturing services.
Is Teknimed a public or private company?
Teknimed is a private company. It is classified as family owned and is currently operating.
When was Teknimed founded?
Teknimed was founded in 1990. It employs 11 to 50 people.
Where is Teknimed based?
Teknimed is headquartered in Vic-en-bigorre, France, in the Europe region.
How does Teknimed make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are OEM and Private Label Manufacturing.
Who are Teknimed's main competitors?
Broad incumbents on record are Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson) and Medtronic (Spine division). Direct peers are Heraeus Medical, Bioventus, BoneSupport, Orthofix, Anika Therapeutics and Biomatlante.
Does Teknimed have an API?
No public API is recorded for Teknimed.
What industry is Teknimed in?
Teknimed's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAHAEAF, Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair). Its NAICS code is 339113 and its SIC code is 3842.